|
Name |
1-Hydroxyboivinianic acid
|
Molecular Formula | C12H12O5 | |
IUPAC Name* |
3-hydroxy-4-(2-methyl-5-oxooxolan-2-yl)benzoic acid
|
|
SMILES |
CC1(CCC(=O)O1)C2=C(C=C(C=C2)C(=O)O)O
|
|
InChI |
InChI=1S/C12H12O5/c1-12(5-4-10(14)17-12)8-3-2-7(11(15)16)6-9(8)13/h2-3,6,13H,4-5H2,1H3,(H,15,16)
|
|
InChIKey |
QBZZGMOAQWNCHR-UHFFFAOYSA-N
|
|
Synonyms |
1-hydroxyboivinianic acid; J3.577.743A; 3-Hydroxy-4-(2-methyl-5-oxotetrahydrofuran-2-yl)benzoic acid
|
|
CAS | NA | |
PubChem CID | 132526850 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 236.22 | ALogp: | 1.1 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 83.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.769 |
Caco-2 Permeability: | -5.339 | MDCK Permeability: | 0.00001160 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.023 | 20% Bioavailability (F20%): | 0.027 |
30% Bioavailability (F30%): | 0.393 |
Blood-Brain-Barrier Penetration (BBB): | 0.266 | Plasma Protein Binding (PPB): | 53.52% |
Volume Distribution (VD): | 0.252 | Fu: | 50.41% |
CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.331 |
CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.051 |
CYP2C9-inhibitor: | 0.03 | CYP2C9-substrate: | 0.137 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.125 |
CYP3A4-inhibitor: | 0.093 | CYP3A4-substrate: | 0.123 |
Clearance (CL): | 7.003 | Half-life (T1/2): | 0.926 |
hERG Blockers: | 0.023 | Human Hepatotoxicity (H-HT): | 0.096 |
Drug-inuced Liver Injury (DILI): | 0.814 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.024 | Maximum Recommended Daily Dose: | 0.012 |
Skin Sensitization: | 0.094 | Carcinogencity: | 0.063 |
Eye Corrosion: | 0.008 | Eye Irritation: | 0.238 |
Respiratory Toxicity: | 0.045 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004186 | 1.000 | D01WJL | 0.316 | ||||
ENC004190 | 0.565 | D0C4YC | 0.316 | ||||
ENC002280 | 0.565 | D0N0RU | 0.289 | ||||
ENC004192 | 0.556 | D0Y7PG | 0.282 | ||||
ENC000002 | 0.442 | D07HBX | 0.281 | ||||
ENC004350 | 0.419 | D0BA6T | 0.269 | ||||
ENC000296 | 0.418 | D0V9EN | 0.266 | ||||
ENC005711 | 0.385 | D02DPU | 0.264 | ||||
ENC001626 | 0.381 | D08HVR | 0.258 | ||||
ENC005619 | 0.377 | D0P7JZ | 0.257 |